Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 11
Submit an article Journal homepage
55
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Low Dose Thalidomide in Patients with Relapsed or Refractory Multiple Myeloma

M. Kees Division of Haematology and Blood Coagulation, Department of Internal Medicine I University of Vienna Vienna Austria
,
G. Dimou Division of Haematology and Blood Coagulation, Department of Internal Medicine I University of Vienna Vienna Austria
,
C. Sillaber Division of Haematology and Blood Coagulation, Department of Internal Medicine I University of Vienna Vienna Austria
,
J. Drach Division of Clinical Oncology, Department of Internal Medicine I University of Vienna Vienna Austria
,
J. Ackermann Division of Clinical Oncology, Department of Internal Medicine I University of Vienna Vienna Austria
,
K. Lechner Division of Haematology and Blood Coagulation, Department of Internal Medicine I University of Vienna Vienna Austria
&
H. Gisslinger Division of Haematology and Blood Coagulation, Department of Internal Medicine I University of Vienna Vienna Austria
 show all
Pages 1943-1946 | Published online: 01 Jul 2009

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Selmin A Ataergin, Tamila Kindwall-Keller, Nathan A Berger & Hillard M Lazarus. (2009) New generation pharmacotherapy in elderly multiple myeloma patients. Expert Opinion on Pharmacotherapy 10:1, pages 81-98.
Read now
Ramón García-Sanz. (2006) Thalidomide in multiple myeloma. Expert Opinion on Pharmacotherapy 7:2, pages 195-213.
Read now
Linda Mileshkin & H. Miles Prince. (2006) The troublesome toxicity of peripheral neuropathy with thalidomide. Leukemia & Lymphoma 47:11, pages 2276-2279.
Read now
G. Cherian, D. W. Thomas & S. A. J. Rule. (2006) The efficacy of low dose thalidomide in refractory/relapsed myeloma—a retrospective audit. Leukemia & Lymphoma 47:11, pages 2409-2411.
Read now
Mathias Kees, Markus Raderer, Sylvia Metz-Schimmerl, Andreas Chott & Heinz Gisslinger. (2005) Very good partial response in a patient with MALT-lymphoma of the lung after treatment with low-dose thalidomide. Leukemia & Lymphoma 46:9, pages 1379-1382.
Read now

Articles from other publishers (8)

Matthew J. Streetly, Jacob Laubach, Paul Richardson & Stephen A. Schey. 2013. Myeloma. Myeloma 144 166 .
Todd Zimmerman. (2009) Immunomodulatory agents in oncology. Update on Cancer Therapeutics 3:4, pages 170-181.
Crossref
Sylvia Feyler, Andy Rawstron, Graham Jackson, John A. Snowden, Kim Cocks & Roderick J. Johnson. (2007) Thalidomide maintenance following high-dose therapy in multiple myeloma: a UK myeloma forum phase 2 study. British Journal of Haematology 139:3, pages 429-433.
Crossref
Axel Glasmacher, Corinna Hahn, Florian Hoffmann, Ralph Naumann, Hartmut Goldschmidt, Marie Lilienfeld-Toal, Katjana Orlopp, Ingo Schmidt-Wolf & Marcus Gorschluter. (2006) A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma. British Journal of Haematology 132:5, pages 584-593.
Crossref
Klaus Podar, Teru Hideshima, Yu-Tzu Tai, Paul G Richardson, Dharminder Chauhan & Kenneth C Anderson. (2006) Emerging Therapies for Multiple Myeloma. American Journal of Cancer 5:3, pages 141-153.
Crossref
Sjoerd Hovenga, Simon M. G. J. Daenen, Joost T. M. de Wolf, Gustaaf W. van Imhoff, Hanneke C. Kluin-Nelemans, Wim J. Sluiter & Edo Vellenga. (2004) Combined thalidomide and cyclophosphamide treatment for refractory or relapsed multiple myeloma patients: a prospective phase II study. Annals of Hematology 84:5, pages 311-316.
Crossref
. (2004) Current Awareness in Hematological Oncology. Hematological Oncology 22:2, pages 73-84.
Crossref
Heinz Gisslinger & Mathias Kees. (2003) Therapy strategies for multiple myeloma: current statusTherapiestrategien für multiple Myelome: rezente Entwicklungen. Wiener Klinische Wochenschrift 115:13-14, pages 451-461.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.